Why the study?
Does clinical risk assessment and targeted thrombophilia screening improve management and reduce venous thromboembolism in pregnant women?
Population
Pregnant women, particularly those with a personal or family history of venous thromboembolism, obesity, or…
Design
Review
Authors
Loading...
Prioritizes clinical risk identification to lower pregnancy VTE; leaves open prospective validation of targeted screening.
Does clinical risk assessment and targeted thrombophilia screening improve management and reduce venous thromboembolism in pregnant women?
Clinical risk assessment and targeted thrombophilia screening in early pregnancy are crucial for managing and reducing the risk of venous thromboembolism in pregnant women.
McColl et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: